These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 20363633)

  • 41. Quaternary ammonium substituted thieno[3,2-e]-1,2-thiazine-6-sulfonamide 1,1-dioxides: Potential membrane-impermeable inhibitors of carbonic anhydrase.
    May JA; Namil A; Chen HH; Dantanarayana AP; Dupré B; Liao JC
    Bioorg Med Chem; 2006 Mar; 14(6):2052-9. PubMed ID: 16297631
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Carbonic anhydrase inhibitors. Inhibition of the Rv1284 and Rv3273 beta-carbonic anhydrases from Mycobacterium tuberculosis with diazenylbenzenesulfonamides.
    Maresca A; Carta F; Vullo D; Scozzafava A; Supuran CT
    Bioorg Med Chem Lett; 2009 Sep; 19(17):4929-32. PubMed ID: 19651511
    [TBL] [Abstract][Full Text] [Related]  

  • 43. QSAR study on carbonic anhydrase inhibitors: aromatic/heterocyclic sulfonamides containing 8-quinoline-sulfonyl moieties, with topical activity as antiglaucoma agents.
    Agrawal VK; Bano S; Supuran CT; Khadikar PV
    Eur J Med Chem; 2004 Jul; 39(7):593-600. PubMed ID: 15236839
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Binding affinity of substituted ureido-benzenesulfonamide ligands to the carbonic anhydrase receptor: a theoretical study of enzyme inhibition.
    Sahu C; Sen K; Pakhira S; Mondal B; Das AK
    J Comput Chem; 2013 Aug; 34(22):1907-16. PubMed ID: 23712937
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Carbonic anhydrase inhibitors. Phenacetyl-, pyridylacetyl- and thienylacetyl-substituted aromatic sulfonamides act as potent and selective isoform VII inhibitors.
    Güzel O; Innocenti A; Scozzafava A; Salman A; Supuran CT
    Bioorg Med Chem Lett; 2009 Jun; 19(12):3170-3. PubMed ID: 19435663
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Protein surface-assisted enhancement in the binding affinity of an inhibitor for recombinant human carbonic anhydrase-II.
    Banerjee AL; Swanson M; Roy BC; Jia X; Haldar MK; Mallik S; Srivastava DK
    J Am Chem Soc; 2004 Sep; 126(35):10875-83. PubMed ID: 15339172
    [TBL] [Abstract][Full Text] [Related]  

  • 47. 3D-QSAR study of benzene sulfonamide analogs as carbonic anhydrase II inhibitors.
    Sethi KK; Verma SM; Prasanthi N; Sahoo SK; Parhi RN; Suresh P
    Bioorg Med Chem Lett; 2010 May; 20(10):3089-93. PubMed ID: 20443227
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Carbonic anhydrase inhibitors: Valdecoxib binds to a different active site region of the human isoform II as compared to the structurally related cyclooxygenase II "selective" inhibitor celecoxib.
    Di Fiore A; Pedone C; D'Ambrosio K; Scozzafava A; De Simone G; Supuran CT
    Bioorg Med Chem Lett; 2006 Jan; 16(2):437-42. PubMed ID: 16290146
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Carbonic anhydrase inhibitors: clash with Ala65 as a means for designing inhibitors with low affinity for the ubiquitous isozyme II, exemplified by the crystal structure of the topiramate sulfamide analogue.
    Winum JY; Temperini C; El Cheikh K; Innocenti A; Vullo D; Ciattini S; Montero JL; Scozzafava A; Supuran CT
    J Med Chem; 2006 Nov; 49(24):7024-31. PubMed ID: 17125255
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Intrinsic thermodynamics of sulfonamide inhibitor binding to human carbonic anhydrases I and II.
    Morkūnaitė V; Gylytė J; Zubrienė A; Baranauskienė L; Kišonaitė M; Michailovienė V; Juozapaitienė V; Todd MJ; Matulis D
    J Enzyme Inhib Med Chem; 2015 Apr; 30(2):204-11. PubMed ID: 24758348
    [TBL] [Abstract][Full Text] [Related]  

  • 51. One-Pot Procedure for the Synthesis of Asymmetric Substituted Ureido Benzene Sulfonamides as Effective Inhibitors of Carbonic Anhydrase Enzymes.
    Vannozzi G; Vullo D; Angeli A; Ferraroni M; Combs J; Lomelino C; Andring J; Mckenna R; Bartolucci G; Pallecchi M; Lucarini L; Sgambellone S; Masini E; Carta F; Supuran CT
    J Med Chem; 2022 Jan; 65(1):824-837. PubMed ID: 34958217
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Exploring structural properties of potent human carbonic anhydrase inhibitors bearing a 4-(cycloalkylamino-1-carbonyl)benzenesulfonamide moiety.
    Buemi MR; Di Fiore A; De Luca L; Angeli A; Mancuso F; Ferro S; Monti SM; Buonanno M; Russo E; De Sarro G; De Simone G; Supuran CT; Gitto R
    Eur J Med Chem; 2019 Feb; 163():443-452. PubMed ID: 30530195
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Synthesis and evaluation of new carbonic anhydrase inhibitors.
    Xiao Z; Duan R; Cui W; Zhang Y; Zhang S; Chen F; Zhang Y; Liu J; Zhang D; Meng Y; Wang L; Wang H
    Bioorg Med Chem; 2011 May; 19(10):3221-8. PubMed ID: 21524585
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparison of sulfamate and sulfamide groups for the inhibition of carbonic anhydrase-II by using topiramate as a structural platform.
    Maryanoff BE; McComsey DF; Costanzo MJ; Hochman C; Smith-Swintosky V; Shank RP
    J Med Chem; 2005 Mar; 48(6):1941-7. PubMed ID: 15771438
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Carbonic anhydrase inhibitors: synthesis of water soluble sulfonamides incorporating a 4-sulfamoylphenylmethylthiourea scaffold, with potent intraocular pressure lowering properties.
    Casini A; Scozzafava A; Mincione F; Menabuoni L; Supuran CT
    J Enzyme Inhib Med Chem; 2002 Oct; 17(5):333-43. PubMed ID: 12683750
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Synthesis and carbonic anhydrase inhibitory properties of novel bromophenols including natural products.
    Balaydın HT; Soyut H; Ekinci D; Göksu S; Beydemir S; Menzek A; Sahin E
    J Enzyme Inhib Med Chem; 2012 Feb; 27(1):43-50. PubMed ID: 21635211
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Synthesis and carbonic anhydrase inhibitory properties of novel cyclohexanonyl bromophenol derivatives.
    Balaydın HT; Sentürk M; Menzek A
    Bioorg Med Chem Lett; 2012 Feb; 22(3):1352-7. PubMed ID: 22230050
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Benzensulfonamides bearing spyrohydantoin moieties act as potent inhibitors of human carbonic anhydrases II and VII and show neuropathic pain attenuating effects.
    Angeli A; Di Cesare Mannelli L; Ghelardini C; Peat TS; Bartolucci G; Menicatti M; Carta F; Supuran CT
    Eur J Med Chem; 2019 Sep; 177():188-197. PubMed ID: 31136893
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Sulfamates of methyl triterpenoates are effective and competitive inhibitors of carbonic anhydrase II.
    Schwarz S; Sommerwerk S; Lucas SD; Heller L; Csuk R
    Eur J Med Chem; 2014 Oct; 86():95-102. PubMed ID: 25147151
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Design, synthesis and biological evaluation of carbohydrate-based sulphonamide derivatives as topical antiglaucoma agents through selective inhibition of carbonic anhydrase II.
    Hou Z; Li C; Liu Y; Zhang M; Wang Y; Fan Z; Guo C; Lin B; Liu Y
    J Enzyme Inhib Med Chem; 2020 Dec; 35(1):383-390. PubMed ID: 31865756
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.